KOD Stock Summary and Trading Ideas (Kodiak Sciences | NASDAQ:KOD)

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Kodiak Sciences trades on the NASDAQ stock market under the symbol KOD.

As of January 22, 2026, KOD stock price climbed to $28.37 with 332,116 million shares trading.

KOD has a beta of 2.78, meaning it tends to be more sensitive to market movements. KOD has a correlation of 0.14 to the broad based SPY ETF.

KOD has a market cap of $1.73 billion. This is considered a Small Cap stock.

In the last 3 years, KOD traded as high as $31.18 and as low as $1.37.

The top ETF exchange traded funds that KOD belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

KOD has outperformed the market in the last year with a price return of +278.3% while the SPY ETF gained +15.6%. KOD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +49.3% and +4.8%, respectively, while the SPY returned +3.1% and +0.1%, respectively.

KOD support price is $25.22 and resistance is $28.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KOD shares will trade within this expected range on the day.